| 1 |
21270118 | Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study. | 2011 Aug |
1 |
| 2 |
19788684 | Development of HCC in patients receiving adefovir dipivoxil for lamivudine-resistant hepatitis B virus mutants. | 2010 Feb |
4 |
| 3 |
20471129 | Risk assessment for the development of hepatocellular carcinoma: according to on-treatment viral response during long-term lamivudine therapy in hepatitis B virus-related liver disease. | 2010 Jul |
3 |
| 4 |
20483498 | Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review. | 2010 Aug |
1 |
| 5 |
21161015 | Surgical treatment of HCC in a patient with lamivudine-resistant hepatitis B cirrhosis with adefovir dipivoxil. | 2010 Aug 27 |
1 |
| 6 |
19092267 | Epidemiology of hepatocellular carcinoma in Japan and Korea. A review. | 2008 |
1 |
| 7 |
17914972 | Efficacy of antiviral therapy with lamivudine after initial treatment for hepatitis B virus-related hepatocellular carcinoma. | 2007 Nov |
5 |
| 8 |
20485632 | Prevention by Lamivudine of hepatocellular carcinoma in patients infected with hepatitis B virus. | 2007 Dec |
4 |
| 9 |
16108176 | HBV and liver cancer. | 2005 Jul |
1 |
| 10 |
16286955 | Lamivudine treatment in patients with HBV-related hepatocellular carcinoma--using an untreated, matched control cohort. | 2005 Oct |
4 |